查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404857

专题 CDMO 市场规模、份额、趋势分析报告：按产品类型、服务类型、最终用途、地区和细分市场进行预测，2024-2030 年

Topical Drugs CDMO Market Size, Share & Trends Analysis Report By Product Type (Semi-solid Formulations, Liquid Formulations Drugs), By Service Type (Contract Development, Contract Manufacturing), By End-use, By Region, & Segment Forecasts, 2024-2030
出版日期: | 出版商: Grand View Research | 英文 195 Pages | 商品交期: 2-10个工作天内

价格

外用药物 CDMO 市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球主题CDMO市场规模将达到878.8亿美元。

预计2024年至2030年该市场将以11.4%的复合年增长率成长。对治疗各种皮肤相关疾病和皮肤病的专门外用药物的需求日益增长。医疗保健提供者和患者正在寻求客製化解决方案，从而导致对具有外用药物专业知识的 CDMO 的需求增加。

市场分散，多家公司拥有相似的技术力和加工能力。随着乳化、奈米技术和经皮吸收贴片创新药物传递技术的发展，CDMO 的能力正在增强，以开发更多对患者友善且有效的外用药物。此外，个人化医疗的不断增长趋势极大地增加了对局部 CDMO 的需求。 CDMO 在根据每位患者的病情和需求个体化局部药物治疗方面发挥着重要作用。

CDMO 与製药公司之间的合作不断增加，CDMO 为创新外用药物的生产和开发做出了贡献。製药公司通常选择外包来专注于研究、分销和行销等核心能力，同时将製造服务委託给专业的 CDMO。 FDA核准外用药物和产品上市的增加极大地促进了专门生产外用药物的 CDMO 的成长。例如，2022 年 5 月，Dermavant Sciences 的 VTAMA (Tapinarov) Cream 1% 获得美国食品药物管理局(FDA)核准，用于局部治疗成人斑块型干癣。

COVID-19 大流行对市场产生了负面影响。疫情严重扰乱了全球供应链，影响了製造能力和原料供应。出于安全考虑，一些涉及外用药物的临床试验已暂时推迟或搁置。这阻碍了新的局部治疗和製剂的测试和开发。然而，透过采取收购以及与专业药品供应商合作等策略性倡议，该行业到 2021 年重新夺回了市场占有率。

专题 CDMO 市场报告亮点

  • 依产品类型划分，半固态製剂产业占最大的销售份额，2023年将达到66.2%。对乳霜、凝胶和软膏的需求不断增长，以及涉及外用药物的临床试验的增加推动了该行业的发展。另一方面，由于针对多种医疗状况的外用乳膏的核准不断提高，乳膏子类别占有很大份额。
  • 根据服务类型，契约製造业务在 2023 年占据最大收入份额，达到 63.9%。该领域的高市场份额主要是由于製造外包成本效益的推动，对合约製造服务的需求不断增加。
  • 以最终用途计算，由于更关注与外用药物开发相关的研发活动，预计生物製药产业在预测期内的复合年增长率为 11.6%。
  • 预计亚太地区在预测期内的复合年增长率为 12.2%。该地区的显着增长主要是由于几个亚洲经济体的人事费用和运营成本较低，因此外用药物的生产具有成本效益。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 热门 CDMO 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 外用药物 CDMO 市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第四章 外用药物 CDMO 市场：产品类型估算及趋势分析

  • 局部药物 CDMO 市场，依产品类型：细分仪表板
  • 热门 CDMO 市场（依产品类型）：波动分析
    • 固体製剂
    • 液体製剂药品
    • 固态製剂
    • 经皮吸收产品

第五章 外用药物 CDMO 市场：服务类型估计与趋势分析

  • 局部药物 CDMO 市场，依服务类型：细分仪表板
  • 外用药物 CDMO 市场（依服务类型）：波动分析
    • 合约开发
    • 契约製造

第六章 外用药物 CDMO 市场：最终用途估计与趋势分析

  • 热门 CDMO 市场（依最终用途）：细分仪表板
  • 专题 CDMO 市场（依最终用途）：波动分析
    • 製药公司
    • 生物製药公司
    • 其他的

第七章 外用药物 CDMO 市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 市场参与企业分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 2023 年公司市场占有率分析
  • 公司简介
    • Lubrizol Life Science
    • Cambrex Corporation
    • Contract Pharmaceuticals Limited
    • Bora Pharmaceutical CDMO
    • Ascendia Pharmaceuticals
    • Pierre Fabre group
    • Piramal Pharma Solutions
    • DPT Laboratories, LTD
    • MedPharm Ltd
    • PCI Pharma Services
Product Code: GVR-4-68040-150-0

Topical Drugs CDMO Market Growth & Trends:

The global topical drugs CDMO market size is expected to reach USD 87.88 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.4% from 2024 to 2030. There is an increasing need for specialized topical drugs to address various skin-related and dermatological conditions. Healthcare providers and patients seek customized solutions, leading to a rise in demand for CDMOs with specialized expertise in topical drugs.

The market is fragmented, with several players having similar technological and processing capabilities. The development of innovative drug delivery technologies, such as microemulsions, nanotechnology, and transdermal patches, has extended the abilities of CDMOs to create more patient-friendly and effective topical drug products. Furthermore, a growing trend towards personalized medicine has significantly boosted demand for topical drug CDMOs, as they play a fundamental role in personalizing topical treatments to individual patient conditions and needs.

Collaborations between CDMOs and pharmaceutical companies have risen, with CDMOs contributing to the manufacturing and development of innovative and new topical drugs. Pharmaceutical firms significantly opt for outsourcing with an aim to focus on core competencies such as research, distribution, and marketing while entrusting manufacturing services to dedicated CDMOs. The increasing number of FDA approvals and product launches in topical medications significantly contributes to CDMOs specializing in topical drug manufacturing growth. For instance, in May 2022, Dermavant Sciences received the U.S. Food and Drug Administration (FDA) approval for its VTAMA (tapinarof) cream, 1%, for the topical management of plaque psoriasis in adults.

The COVID-19 pandemic negatively impacted the market. The pandemic has significantly disrupted the global supply chains, affecting the accessibility of manufacturing capabilities and raw materials. Several clinical studies, including those for topical medicine, were temporarily delayed or put on hold owing to safety concerns. This disturbed the testing and development of new topical drug treatments and formulations. However, by adopting strategic initiatives such as acquisition and partnerships with specialized drug providers, the industry regained its market shares by 2021.

Topical Drugs CDMO Market Report Highlights:

  • Based on product type, the semi-solid formulations segment held the largest revenue share of 66.2% in 2023.The segment is driven by the growing demand for creams, gels, and ointments and the rise in clinical trials involving topical drugs. The cream sub-category, on the other hand, held the lion's share owing to increasing approval of topical creams for several medical conditions
  • Based on the service type, the contract manufacturing segment held the largest revenue share of 63.9% in 2023. The high shares of the segment are majorly due to the growing demand for outsourced manufacturing services, driven by the cost-effectiveness of outsourced manufacturing
  • In terms of end-use, the biopharmaceutical companies segment is anticipated to witness the fastest CAGR of 11.6% over the forecast period owing to the rise in focus on R&D activities pertaining to the development of topical medication
  • Asia Pacific is anticipated to register the fastest CAGR of 12.2% over the forecast period. The region's substantial growth is primarily attributed to the cost-effective manufacturing of topical products due to lower labor and operational costs in several Asian economies

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Product Type
    • 1.1.3. Service Type
    • 1.1.4. End-use
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective-1
    • 1.4.2. Objective-2
    • 1.4.3. Objective-3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Topical Drugs CDMO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High demand for non-invasive treatment options to boost sales of topical drugs
      • 3.2.1.2. Growing pipeline of topical drugs
      • 3.2.1.3. Growing research and development investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance with strict regulatory requirements
      • 3.2.2.2. Limited efficacy in certain conditions limits adoption of topical products
  • 3.3. Topical Drugs CDMO Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat Of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Topical Drugs CDMO Market: Product Type Estimates & Trend Analysis

  • 4.1. Topical Drugs CDMO Market, By Product Type: Segment Dashboard
  • 4.2. Topical Drugs CDMO Market, By Product Type: Movement Analysis
  • 4.3. Topical Drugs CDMO Market Estimates & Forecasts, By Product Type, 2018 - 2030
    • 4.3.1. Semi-solid Formulations
      • 4.3.1.1. Semi-solid Formulations Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Creams
      • 4.3.1.2.1. Creams Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Ointments
      • 4.3.1.3.1. Ointments Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Gel
      • 4.3.1.4.1. Gel Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.5. Others
      • 4.3.1.5.1. Others Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 4.3.2. Liquid Formulations Drugs
      • 4.3.2.1. Liquid Formulations Drugs Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 4.3.3. Solid Formulations
      • 4.3.3.1. Solid Formulations Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 4.3.4. Transdermal Products
      • 4.3.4.1. Transdermal Products Topical Drugs CDMO Market, 2018 to 2030 (USD Million)

Chapter 5. Topical Drugs CDMO Market: Service Type Estimates & Trend Analysis

  • 5.1. Topical Drugs CDMO Market, By Service Type: Segment Dashboard
  • 5.2. Topical Drugs CDMO Market, By Service Type: Movement Analysis
  • 5.3. Topical Drugs CDMO Market Estimates & Forecasts, By Service Type, 2018 - 2030
    • 5.3.1. Contract Development
      • 5.3.1.1. Contract Development Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 5.3.2. Contract Manufacturing
      • 5.3.2.1. Contract Manufacturing Topical Drugs CDMO Market, 2018 to 2030 (USD Million)

Chapter 6. Topical Drugs CDMO Market: End-use Estimates & Trend Analysis

  • 6.1. Topical Drugs CDMO Market, By End-use: Segment Dashboard
  • 6.2. Topical Drugs CDMO Market, By End-use: Movement Analysis
  • 6.3. Topical Drugs CDMO Market Estimates & Forecasts, By End-use, 2018 - 2030
    • 6.3.1. Pharmaceutical Companies
      • 6.3.1.1. Pharmaceutical Companies Topical Drugs CDMO Market 2018 to 2030 (USD Million)
    • 6.3.2. Biopharmaceutical Companies
      • 6.3.2.1. Biopharmaceutical Companies Topical Drugs CDMO Market 2018 to 2030 (USD Million)
    • 6.3.3. Others
      • 6.3.3.1. Others Topical Drugs CDMO Market 2018 to 2030 (USD Million)

Chapter 7. Topical Drugs CDMO Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Competitive Scenario
      • 7.5.1.3. Regulatory Framework
      • 7.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Competitive Scenario
      • 7.6.1.3. Regulatory Framework
      • 7.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 7.6.2. India
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 7.6.4. South Korea
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Competitive Scenario
      • 7.7.1.3. Regulatory Framework
      • 7.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 7.7.2. Mexico
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Competitive Scenario
      • 7.8.1.3. Regulatory Framework
      • 7.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Innovators
    • 8.1.2. Market Leaders
    • 8.1.3. Emerging Players
    • 8.1.4. Company Market Share Analysis, 2023
  • 8.2. Company Profiles
    • 8.2.1. Lubrizol Life Science
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Cambrex Corporation
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Contract Pharmaceuticals Limited
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Bora Pharmaceutical CDMO
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Ascendia Pharmaceuticals
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Pierre Fabre group
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Piramal Pharma Solutions
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. DPT Laboratories, LTD
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. MedPharm Ltd
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. PCI Pharma Services
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 5 North America Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 6 North America Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 7 North America Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 11 U.S. Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 15 Canada Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 17 Europe Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 20 Europe Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 22 UK Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 23 UK Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 24 UK Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 25 Germany Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 28 Germany Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 France Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 30 France Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 31 France Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 32 France Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 36 Italy Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 Spain Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 38 Spain Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 39 Spain Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 40 Spain Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 Denmark Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 42 Denmark Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 44 Denmark Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Sweden Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 48 Sweden Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Norway Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 50 Norway Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 51 Norway Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 52 Norway Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 China Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 59 China Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 60 China Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 61 China Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 62 Japan Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 65 Japan Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 India Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 67 India Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 68 India Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 69 India Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Australia Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 71 Australia Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 72 Australia Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 73 Australia Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 77 South Korea Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 78 Thailand Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 79 Thailand Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 80 Thailand Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 81 Thailand Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 82 Latin America Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 83 Latin America Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 84 Latin America Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 85 Latin America Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 86 Latin America Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Brazil Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 88 Brazil Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 89 Brazil Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 90 Brazil Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Mexico Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 92 Mexico Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 93 Mexico Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 94 Mexico Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 95 Argentina Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 96 Argentina Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 98 Argentina Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 102 Middle East & Africa Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 103 Middle East and Africa Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 104 South Africa Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 105 South Africa Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 107 South Africa Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 112 UAE Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 113 UAE Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 115 UAE Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Primary research pattern
  • Fig. 8 Primary interviews in North America
  • Fig. 9 Primary interviews in Europe
  • Fig. 10 Primary interviews in the Asia Pacific
  • Fig. 11 Primary interviews in Latin America
  • Fig. 12 Primary interviews in MEA
  • Fig. 13 Market Snapshot
  • Fig. 14 Segment Snapshot
  • Fig. 15 Segment Snapshot
  • Fig. 16 Competitive Landscape Snapshot
  • Fig. 17 Topical Drugs CDMO market segmentation
  • Fig. 18 Parent market outlook (2023)
  • Fig. 19 Related/ancillary market outlook (2023)
  • Fig. 20 Market driver relevance analysis (Current & future impact)
  • Fig. 21 Market restraint relevance analysis (Current & future impact)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 SWOT analysis, by a factor (political & legal, economic and technological)
  • Fig. 24 Topical Drugs CDMO Market Product Type outlook: Segment dashboard
  • Fig. 25 Topical Drugs CDMO: Product Type movement analysis
  • Fig. 26 Semi-solid Formulations market, 2018 - 2030 (USD Million)
  • Fig. 27 Creams market, 2018 - 2030 (USD Million)
  • Fig. 28 Ointments market, 2018 - 2030 (USD Million)
  • Fig. 29 Gel market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Liquid Formulations Drugs market, 2018 - 2030 (USD Million)
  • Fig. 32 Solid Formulations market, 2018 - 2030 (USD Million)
  • Fig. 33 Transdermal Products market, 2018 - 2030 (USD Million)
  • Fig. 34 Topical Drugs CDMO Market Service Type outlook: Segment dashboard
  • Fig. 35 Topical Drugs CDMO: Service Type type movement analysis
  • Fig. 36 Contract Development market, 2018 - 2030 (USD Million)
  • Fig. 37 Contract Manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 38 Topical Drugs CDMO market End-use outlook: Segment dashboard
  • Fig. 39 Topical Drugs CDMO market: End-use movement analysis
  • Fig. 40 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
  • Fig. 41 Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
  • Fig. 42 Others market, 2018 - 2030 (USD Million)
  • Fig. 43 Regional marketplace: Segment dashboard
  • Fig. 44 Regional outlook, 2023 & 2030
  • Fig. 45 North America market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market, 2018 - 2030 (USD Million)
  • Fig. 50 UK market, 2018 - 2030 (USD Million)
  • Fig. 51 France market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market, 2018 - 2030(USD Million)
  • Fig. 55 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 58 China market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan market, 2018 - 2030 (USD Million)
  • Fig. 60 India market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East & Africa market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market, 2018 - 2030 (USD Million)